Research Papers

25 of 111 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Correction to: Don't Drive Blind: Driving Pressure to Optimize Ventilator Management in ECMO.
Gupta E; Awsare B; Hirose H; Cavarocchi N; Baram M.
Lung (Unknown)
Published: 2020
Don't Drive Blind: Driving Pressure to Optimize Ventilator Management in ECMO.
Gupta E; Awsare B; Hirose H; Cavarocchi N; Baram M.
Lung (Unknown)
Published: 2020
1/6 Transparent
The Relationship Between Cough Reflex Sensitivity and Exacerbation Frequency in Chronic Obstructive Pulmonary Disease.
Cho PSP; Fletcher HV; Turner RD; Patel IS; Jolley CJ; Birring SS.
Lung (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
Sobiecka M; Lewandowska K; Kober J; Franczuk M; Skoczylas A; Tomkowski W; Kuś J; Szturmowicz M.
Lung (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Nicorandil, a K<sub>ATP</sub> Channel Opener, Attenuates Ischemia-Reperfusion Injury in Isolated Rat Lungs.
Abe K; Horiguchi T; Enzan K; Masaki Y; Nishikawa T; Kimura T.
Lung (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Ranking Self-reported Gastrointestinal Side Effects of Pharmacotherapy in Sarcoidosis.
Drent M; Proesmans VLJ; Elfferich MDP; Jessurun NT; de Jong SMG; Ebner NM; Lewis EDO; Bast A.
Lung (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure.
Meservey AJ; Burton MC; Priest J; Teneback CC; Dixon AE.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.
Wronski SL; Mordin M; Kelley K; Anguiano RH; Classi P; Shen E; Manaker S.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Electronic Cigarette Advertising Impacts Adversely on Smoking Behaviour Within a London Student Cohort: A Cross-Section…
Ratneswaran C; Steier J; Reed K; Khong TK.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Physical Inactivity in Pulmonary Sarcoidosis.
Cho PSP; Vasudevan S; Maddocks M; Spinou A; Chamberlain Mitchell S; Wood C; Jolley CJ; Birring SS.
Lung (Unknown)
Published: 2019
1/6 Transparent
Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD.
Böcskei RM; Benczúr B; Losonczy G; Illyés M; Cziráki A; Müller V; Bohács A; Bikov A.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
The Burden of Sarcoidosis Symptoms from a Patient Perspective.
Voortman M; Hendriks CMR; Elfferich MDP; Bonella F; Møller J; De Vries J; Costabel U; Drent M.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Investigation of Urinary Sestrin2 in Patients with Obstructive Sleep Apnea.
Bai L; Sun C; Zhai H; Chen C; Hu X; Ye X; Li M; Fang Y; Yang W; Wang H; Sun S.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Degradation of Lung Protective Angiotensin Converting Enzyme-2 by Meconium in Human Alveolar Epithelial Cells: A Potent…
Gandhi CK; Holmes R; Gewolb IH; Uhal BD.
Lung (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH.
Gall H; Vachiéry JL; Tanabe N; Halank M; Orozco-Levi M; Mielniczuk L; Chang M; Vogtländer K; Grünig E.
Lung (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
IL-8 Gene Variants and Expression in Childhood Asthma.
Charrad R; Kaabachi W; Rafrafi A; Berraies A; Hamzaoui K; Hamzaoui A.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Comparative Meta-Analysis of the Efficacy of Once-Daily Fluticasone Furoate 100 µG Versus Twice-Daily Fluticasone Propi…
Tomlinson R; Parks D; Martin A.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
The Objective Assessment of Cough Frequency in Bronchiectasis.
Spinou A; Lee KK; Sinha A; Elston C; Loebinger MR; Wilson R; Chung KF; Yousaf N; Pavord ID; Matos S; Garrod R; Birring SS.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Treatment with Geranylgeranylacetone Induces Heat Shock Protein 70 and Attenuates Neonatal Hyperoxic Lung Injury in a M…
Tokuriki S; Igarashi A; Okuno T; Ohta G; Naiki H; Ohshima Y.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Continuous Cough Monitoring Using Ambient Sound Recording During Convalescence from a COPD Exacerbation.
Crooks MG; den Brinker A; Hayman Y; Williamson JD; Innes A; Wright CE; Hill P; Morice AH.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
Guiot J; Moermans C; Henket M; Corhay JL; Louis R.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
The Effect of A Geriatric Assessment on Treatment Decisions for Patients with Lung Cancer.
Schulkes KJ; Souwer ET; Hamaker ME; Codrington H; van der Sar-van der Brugge S; Lammers JJ; Portielje JE; van Elden LJ; van den Bos F.
Lung (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
Morjaria JB; Rigby A; Morice AH.
Lung (Unknown)
Published: 2017
3/6 Transparent
Registered Funding Declared
Reliability and Validity of the Swedish Version of the Hull Airway Reflux Questionnaire (HARQ-S).
Johansson EL; Ternesten-Hasséus E.
Lung (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
The Effect of Fatigue and Fatigue Intensity on Exercise Tolerance in Moderate COPD.
Al-Shair K; Kolsum U; Singh D; Vestbo J.
Lung (Unknown)
Published: 2016
1/6 Transparent